Isokinetic Fatigue Index in a Population of Triathletes

NCT ID: NCT05635422

Last Updated: 2022-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-11-14

Study Completion Date

2024-11-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to evaluate the relevance of carrying out a measure of muscular fatigability by isokinetism, in the search for factors favouring micro-traumatic lesions of the lower limbs in a population of triathletes.

This is a prospective monocentric pilot study of the before/after type in which the patient is his or her own control, in high-level triathletes practising an endurance sport, who have had more than 7 consecutive days off running due to a musculoskeletal injury during the previous sporting year.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Musculoskeletal Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

isokinetism test in high level triathletes practicing an endurance sport

Group Type EXPERIMENTAL

isokinetism test

Intervention Type DIAGNOSTIC_TEST

measure of muscular fatigability by isokinetism

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

isokinetism test

measure of muscular fatigability by isokinetism

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Having had a practical running break of more than 7 consecutive days due to a musculoskeletal injury of a lower limb during the previous sport year
* Willing to comply with all study procedures
* Having given written consent
* Socially insured

Exclusion Criteria

* Pain that does not allow an isokinetic test to be performed
* Knee joint amplitude less than 100° of flexion or flessum greater than 5°.
* History of rupture or ligamentoplasty of the anterior cruciate ligament less than 2 years ago
* History of knee surgery less than 2 years
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boulogne sur Mer Hospital Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Boulogne sur mer Hospital Center

Boulogne-sur-Mer, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Guillaume BERTOUX

Role: CONTACT

+ 33 3 21 99 87 13

Yoann MORVAN

Role: CONTACT

+ 33 3 21 99 33 85

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Justine MONVOISIN

Role: primary

+ 33 3 21 99 34 40

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.